Neurocrine to buy Soleno Therapeutics for $2.9 billion

Thread starter International: Top News And Analysis
Start date Apr 6, 2026

International: Top News And Analysis

Guest

Apr 6, 2026

Neurocrine ⁠has ‌offered $53 per Soleno share ⁠held, which represents a premium of about 34% to the stock's last close.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Neurocrine to buy Soleno Therapeutics for $2.9 billion

Prefix: N/A

Forum: World News

Start date: Apr 6, 2026

Last reply date: Apr 6, 2026

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Apr 6, 2026

Replies: 0

Views: 12

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search